Status:
COMPLETED
Real-time Influenza Vaccine Surveillance
Lead Sponsor:
Columbia University
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Vaccine Safety
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this proposal is to pioneer the implementation and evaluation of a novel patient centered text messaging vaccine adverse event surveillance network.
Detailed Description
The proposal will be conducted at six clinical sites of Columbia University Medical Center (CUMC), using a customized version of our already operational technology platform. Our proposed 12 month proj...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Have an active cell phone with text messaging capability
- Presents for care at participating sites
- Fluent in English or Spanish
Exclusion
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01233388
Start Date
November 1 2010
End Date
May 1 2012
Last Update
June 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Medical Center
New York, New York, United States, 10032